Menu Search
Equities

Japan Animal Referral Medical Center Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6039:TYO

Japan Animal Referral Medical Center Co Ltd

Actions
Consumer DiscretionaryConsumer Services
  • Price (JPY)1,464.00
  • Today's Change88.00 / 6.40%
  • Shares traded196.30k
  • 1 Year change+195.88%
  • Beta0.9089
Data delayed at least 15 minutes, as of Feb 18 2026 02:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Japan Animal Referral Medical Center Co.,Ltd. is engaged in providing animal medical care service. The Company operates animal medical care related business segment. This segment provides three kinds of medical services, including secondary care services, diagnostic imaging services and other related service.

  • Revenue in JPY (TTM)5.74bn
  • Net income in JPY691.41m
  • Incorporated2005
  • Employees294.00
  • Location
    Japan Animal Referral Medical Center Co Ltd2-5-8, Kuji, Takatsu-kuKAWASAKI-SHI 213-0032JapanJPN
  • Phone+81 448501320
  • Fax+81 448501321
  • Websitehttps://www.jarmec.co.jp/
More ▼

Institutional shareholders

11.69%Per cent of shares held by top holders
HolderShares% Held
Pilgrim Partners (Asia) Pte Ltd.as of 23 Jan 20261.13m7.89%
Asset Management One Co., Ltd.as of 15 Jan 2026411.10k2.86%
Dimensional Fund Advisors LPas of 05 Feb 202668.00k0.47%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 30 Sep 202542.50k0.30%
Simplex Asset Management Co., Ltd.as of 05 Feb 202619.10k0.13%
Renta 4 Gestora SGIIC SAas of 31 Dec 20253.49k0.02%
Dimensional Fund Advisors Ltd.as of 30 Nov 20252.50k0.02%
More ▼
Data from 31 Dec 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.